Hearing News Watch

The National Acoustic Laboratories (NAL) has unveiled their latest initiative, “NALguide: Hearing Aid Features Explained,” a comprehensive consumer guide designed to navigate the vast landscape of hearing aid technology in the current market. The guide aims to empower both hearing aid users and the general public to comprehend and make informed choices regarding the array of available hearing aid technologies.

SOMERSET, NEW JERSEY – For nearly 20 years, Oticon, Inc. has been proud to fund scholarships through Sertoma’s Scholarship for Hard of Hearing or Deaf. This year, a $5,000 grant provided by Oticon, Inc. has enabled Sertoma Inc. to again award college scholarships to five exceptional students with hearing loss. Oticon has been a steadfast supporter of the Sertoma Scholarship

NEEDHAM, MASSACHUSSETTS — The Usher Syndrome Society (USH Society), a non-profit organization focused on raising awareness and funds for Usher syndrome (USH) research, has announced the availability of Usher syndrome research grants. Usher syndrome is a genetic condition that progressively affects both the retina and inner ear, leading to combined hearing and vision loss in approximately 400,000 individuals worldwide. The

ISELIN, NEW JERSEY – Signia has announced its continued partnership with the Dallas Cowboys for the second year in a row. The collaboration aims to raise awareness about the importance of hearing health for physical and mental well-being in local communities across Texas, Oklahoma, Arkansas, and New Mexico. The World Health Organization (WHO) reports that approximately 466 million people worldwide

WASHINGTON, D.C. —  Senators Elizabeth Warren (D-Mass), Rand Paul (R-Ky.), and Chuck Grassley (R-Iowa) have introduced the bipartisan Medicare Audiology Access Improvement Act, aiming to grant Medicare beneficiaries access to comprehensive hearing and balance healthcare services provided by licensed audiologists across all states and territories. The bill, co-sponsored by several other senators, seeks to address the significant impact of hearing

CHICAGO, ILLINOIS — Beltone has been recognized as one of the Best Retailers in Hearing Care by Newsweek for 2023. The prestigious award was based on an independent survey conducted by Newsweek and Statista Inc., evaluating customer experiences at retail stores across the United States. The America’s Best Retailers 2023 list was unveiled on July 19, 2023, and Beltone was

AMSTERDAM, NETHERLANDS — The results of the groundbreaking Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, the largest randomized, controlled clinical trial of hearing aids for reducing long-term cognitive decline in older adults, were unveiled for the first time at the Alzheimer’s Association International Conference® (AAIC®) 2023, held in Amsterdam, Netherlands, and online. While the results were negative in

The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study represents a pioneering effort aimed at unlocking a crucial question: Can treating hearing loss in older adults effectively reduce the gradual loss of thinking and memory abilities (cognitive decline) that often precede dementia? With hearing loss affecting 1 in 8 Americans and its rates increasing among older adults, the significance

VIENNA, VIRGINIA — Torryn Brazell, CAE, CFRE, chief executive officer of the American Tinnitus Association (ATA), is leaving her position after six years of dedicated service to the nonprofit organization that exclusively serves the tinnitus community. Following the resignation, the ATA Board of Directors has embarked on a comprehensive search for new executive leadership. Based on support from members, donors,

Sensorion, a clinical-stage biotechnology company specializing in hearing loss disorders, has announced the submission of its first Clinical Trial Application (CTA) to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The CTA is for the phase 1/2 clinical trial of OTOF-GT, a gene therapy aimed at treating otoferlin gene-mediated hearing loss in pediatric patients up to 31 months old.